1. A randomized, placebo‐controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers. (16th November 2013) Authors: Zhang, Meng; Xu, Christine R.; Shamiyeh, Elias; Liu, Feng; Yin, Jian Y.; von Moltke, Lisa L.; Smith, William B. Journal: Journal of clinical pharmacology Issue: Volume 54:Number 4(2014:Apr.) Page Start: 415 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Pharmacokinetics and pharmacodynamics of itepekimab in healthy adults and patients with asthma: Phase I first‐in‐human and first‐in‐patient trials. Issue 2 (29th September 2021) Authors: Kosloski, Matthew P.; Kalliolias, George D.; Xu, Christine R.; Harel, Sivan; Lai, Ching‐Ha; Zheng, Wenjun; Davis, John D.; Kamal, Mohamed A. Journal: Clinical and translational science Issue: Volume 15:Issue 2(2022) Page Start: 384 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗